Milne Jill C. 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Feb 9, 2018
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2018-02-08+230,000→ 230,000 totalExercise: $1.28Exp: 2028-02-07→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 8, 2018 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 8, 2018 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.